CSafe launches transport packaging for gene therapy market

By Damian Brett

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”

Share this story

Related Topics

Latest pharma logistics news

Pegasus ULD global network expansion

Sonoco ThermoSafe has announced a rapid expansion of its Pegasus ULD fleet, a passive aircraft-certified temperature-controlled container accessible via a…

Read More

Share this story

Sao Paolo’s GRU Airport becomes strategic member of Pharma.Aero

Sao Paolo’s GRU Airport in Brazil has becomes a strategic airport member of Pharma.Aero, representing the East South America region….

Read More

Share this story

Saudia Cargo to work with IATA on CEIV-Pharma Certification

Saudia Cargo is to work with IATA on gaining its Center of Excellence for Independent Validators for Pharmaceutical Logistics (CEIV…

Read More

Share this story